Recent Press Releases

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in...

Japanese researchers have developed adaptable nano-capsules that can help in the diagnosis of glioblastoma cells - a highly invasive form of brain tumours.

Tsukuba, Japan, - (ACN Newswire) - Polymersomes are hollow, synthetic, nano-sized capsules. They have been extensively studied for their potential in the targeted delivery of drugs within the body....

Companion Medical announces completion of Series B financing

Eli Lilly and Company investment in Companion will support development of innovative insulin delivery for people living with diabetes. SAN DIEGO, CA, May 20, 2015 -- Companion Medical, Inc., a San...

Direct Flow Medical(R) Reports Excellent Two Year Data for Its Transcatheter Aortic Heart Valve System

May 19, 2015 08:40 AM Eastern Daylight Time SANTA ROSA, Calif. & PARIS--()--Direct Flow Medical®, Inc., an innovative structural heart company, today announced positive two...

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

PARIS, May 19, 2015 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that the first high-risk...

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

PARIS, May 19, 2015 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that the first high-risk...

Alcyone Lifesciences and DNAtrix Enter Clinical Collaboration for Brain Cancer

--Collaboration Combines Companies' Expertise in Oncolytic Virus Therapy and Targeted Drug Delivery-- LOWELL, Mass. and HOUSTON, May 19, 2015 /PRNewswire/ -- Alcyone Lifesciences, Inc., a...

Gel filled with nanosponges cleans up MRSA infections

San Diego, Calif., May 13, 2015 -- Nanoengineers at the University of California, San Diego developed a gel filled with toxin-absorbing nanosponges that could lead to an effective treatment for skin...

Celyad announces filing of registration statement in the United States for a proposed global offering

MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)-- Regulatory News: Celyad SA (Paris:CYAD) (Brussels:CYAD) (formerly known as Cardio3 BioSciences, Euronext Brussels and Paris:CYAD), a leader in the...

Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain

DUBLIN and RALEIGH, N.C., May 14, 2015 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc ENDP, -5.37% (ENL), and BioDelivery Sciences International, Inc. BDSI, -2.85%...

Endo Pharmaceuticals and BioDelivery Sciences Present Pivotal Data from Two Phase 3 Trials Demonstrating Safety and Efficacy of Buprenorphine HCl Buccal Film for the Management of Chronic Pain

DUBLIN and RALEIGH, N.C., May 14, 2015 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc ENDP, -5.37% (ENL), and BioDelivery Sciences International, Inc. BDSI, -2.85%...

Capsugel Extends Inhaled Biotherapeutics Delivery Capability to Phase 2 Clinical Trials

Morristown, N.J. (PRWEB) May 04, 2015 Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced that it has manufactured Phase 2 clinical trial...

A 'super-cool' way to deliver drugs

Tel Aviv University researchers discover the secret to substances that can be engineered to 'freeze' at a specific time AMERICAN FRIENDS OF TEL AVIV UNIVERSITY Water, when cooled below...

NeuroDerm Announces Lifting of FDA Clinical Hold on ND0612, a Subcutaneously Delivered Levodopa/Carbidopa for the Treatment of Parkinson's Disease

ND0612H and ND0612L U.S. Clinical Development Cleared to Proceed REHOVOT, Israel, May 08, 2015 (GLOBE NEWSWIRE via COMTEX) -- NeuroDerm Ltd. NDRM, +10.90% a clinical-stage pharmaceutical company...

Concordia Healthcare Corp. works to expand treatment options for patients with rare cancers

Photodynamic therapy with PHOTOFRIN® being studied in range of cancers OAKVILLE, ON, May 7, 2015 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (TSX:...

Vernalis and Tris Pharma receive FDA approval of NDA for Tuzistra™ XR (codeine polistirex and chlorpheniramine polistirex)

Tuzistra XR offers extended relief of cough in adults with dosing every 12 hours and marks Vernalis' entrance into the U.S. Prescription Cough Cold Market Vernalis plc and Tris Pharma Inc....

NUVASIVE LAUNCHES INTEGRATED GLOBAL ALIGNMENT (IGA™) PLATFORM AT AANS 2015

Company Introduces First of Its Kind Technology for Intraoperative Reconciliation to Ensure Optimal Alignment in Spine Surgery SAN DIEGO, CA – May 4, 2015 – NuVasive, Inc. (NASDAQ: NUVA)...

Lipocine Announces Completion of LPCN 1021, Oral Testosterone, Phase 3 Clinical Trial

SALT LAKE CITY, April 30, 2015 (GLOBE NEWSWIRE) -- Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, today announced the completion of the last patient visit in the safety...

UNC Team uses cellular bubbles to deliver Parkinson's meds directly to brain

Pharmaceutical researchers at UNC are the first to use exosomes -- lipid-and-protein spheres produced by cells -- as vehicles to deliver a potent large-molecule drug to the brain Researchers at the...

Alliqua Biomedical (ALQA) Announces Closing Of $34.5 Million Public Offering Including Exercise Of Underwriters' Option To Purchase Additional Shares

5/4/2015 2:44:46 PM LANGHORNE, Pa., May 4, 2015 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care...